Since the 2018 ISPAD guidelines on this topic, follow‐up of large cohorts from around the
globe have continued informing the current incidence and prevalence of co‐morbidities and …

Purpose of review Insulin resistance (IR) is recognized to play an important role in the
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …

Dyslipidemia is an emerging mechanism in microvascular complications in T2D. Elucidating
the molecular pathomechanisms may pinpoint potential lipid-centric treatments …

Hyperlipidemia is considered as one of the major systemic factors associated with the
development of diabetic retinopathy, and animal models have documented that its presence …

Background Youth onset type 1 diabetes (T1D) and type 2 diabetes (T2D) is increasing and
associated with earlier vascular complications and mortality. Dyslipidemia is an important …

Diabetic retinopathy remains the leading cause of vision loss in working-age adults. The
multi-factorial nature of the disease, along with the complex structure of the retina, have …

Objectives The prevalence of pediatric diabetes is increasing. Dyslipidemia is an important
modifiable cardiovascular disease risk factor often present in children with diabetes. In this …

Abstract Purpose of Review Cardiovascular disease is the leading cause of death in patients
with type 1 diabetes (T1D) and type 2 diabetes (T2D). Subclinical atherosclerotic changes …

Background Cardiovascular disease (CVD) is recognized as a primary and severe
comorbidity in patients with type 2 diabetes mellitus (T2DM) and is also identified as a …

摘要目的: 研究2 型糖尿病患者尿微量白蛋白(MAU) 水平与动脉粥样硬化的相关性. 方法:
抽样选取2015 年2 月至2017 年2 月我体检中心检测的2 型糖尿病患者500 例 …